GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Great Novel Therapeutics Biotech & Medicals (ROCO:7427) » Definitions » Institutional Ownership

Great Novel Therapeutics Biotech & Medicals (ROCO:7427) Institutional Ownership : 0.11% (As of Jun. 11, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Great Novel Therapeutics Biotech & Medicals Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Great Novel Therapeutics Biotech & Medicals's institutional ownership is 0.11%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Great Novel Therapeutics Biotech & Medicals's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Great Novel Therapeutics Biotech & Medicals's Float Percentage Of Total Shares Outstanding is 0.00%.


Great Novel Therapeutics Biotech & Medicals Institutional Ownership Historical Data

The historical data trend for Great Novel Therapeutics Biotech & Medicals's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Great Novel Therapeutics Biotech & Medicals Institutional Ownership Chart

Great Novel Therapeutics Biotech & Medicals Historical Data

The historical data trend for Great Novel Therapeutics Biotech & Medicals can be seen below:

2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30 2024-05-31
Institutional Ownership 0.12 0.12 0.12 0.12 0.12 0.12 0.11 0.11 0.11

Great Novel Therapeutics Biotech & Medicals Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Great Novel Therapeutics Biotech & Medicals (ROCO:7427) Business Description

Traded in Other Exchanges
N/A
Address
No.3, Park Street, Room WR-06, 17th Floor, Nangang District, Taipei, TWN, 11503
Great Novel Therapeutics Biotech & Medicals focuses on drug development to treat advanced cancer. The new drugs ranging from epigenetic modulators, a combination of tumor microenvironment-regulating agents, epigenetic immuno-modulators, to the protein degradation drugs targeting HDACs 1, 2, and 3, are in a developing pipeline. These drugs focus on the field of epigenetics, for the demand of clinical unmet needs in advanced and refractory cancers.

Great Novel Therapeutics Biotech & Medicals (ROCO:7427) Headlines

No Headlines